Shire's Approach: The "golden rule" in outsourcing partnerships | Boston 2016
How do biopharmaceutical companies handle CMO and supplier relationships that stem from M&A activity? In reply, one might recall the old refrain, “Very carefully.” Actually, with a healthy dose of nuance, that’s not far from accurate. Who better to provide that nuance than Shire? The folks there know M&A and outsourcing as well as anyone in the global biopharma industry today. For them, CMO integration, management and assessment traverses three dimensions: quality, process and supply performance.
External web link - https://www.outsourcedpharma.com/doc/for-m-a-shire-stays-three-dimensional-with-cmos-0001